Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Melanoma of the Skin (All Stages^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Count

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


California7


Florida2


Texas7


New York7


Ohio2


Illinois7


North Carolina2


Pennsylvania2


Arizona2


Georgia7


Minnesota2


Michigan2


New Jersey7


Washington1


Virginia2


Maryland2


Wisconsin2


Tennessee2


Indiana2


Kentucky7


Missouri2


South Carolina2


Colorado2


Massachusetts2


Oregon2


Alabama2


Utah7


Iowa7


Louisiana7


Kansas2


Oklahoma2


Connecticut7


Arkansas2


Nevada2


Idaho7


Mississippi2


Nebraska2


West Virginia2


Maine2


New Hampshire2


Hawaii7


New Mexico7


Montana2


Delaware2


South Dakota2


Vermont2


Rhode Island2


North Dakota2


Wyoming2


Puerto Rico2


Alaska2


District of Columbia2





Notes:
Created by statecancerprofiles.cancer.gov on 03/27/2026 12:57 pm.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.